stella
beta
Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib — Stella
Recruiting
Back to Non-squamous NSCLC trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
Israel
Sheba Medical Center, Ramat Gan, Israel
Sheba Medical Center, Jusidman Cancer Center, Ramat Gan, Israel
View full record on ClinicalTrials.gov